US study finds nicotine pouches may help tobacco users quit, but safety remains to be determined

Sep.17
US study finds nicotine pouches may help tobacco users quit, but safety remains to be determined
A recent US study found those who recently quit smoking are 3.9 times more likely to use nicotine pouches.

Key Points:

 

·Trend: A study in the United States found that recent quitters are 3.9 times more likely to use nicotine pouches compared to others.

·User demographics: Nicotine pouch users are primarily smokers, e-cigarette users, and smokeless tobacco users. 

·Quitting potential: Nicotine pouches may play a role in helping some smokers quit. 

·Regulatory updates: The FDA in the United States plans to expedite the review of nicotine pouches from four tobacco companies. 

·Safety concerns: While nicotine pouches may help reduce harm, their long-term safety remains uncertain.

 


 

2Firsts, September 17, 2025 - According to a report from drugs.com on September 15, a new study in the United States suggests that nicotine pouches may be helping tobacco users quit smoking and quit e-cigarettes.

 

These nicotine pouches (such as the Velo and Zyn brands) cannot be marketed as smoking cessation aids like nicotine patches or gum, researchers say.

 

However, researchers recently reported in the Journal of the American Medical Association Network Open that some individuals appear to be using these nicotine pouches to obtain nicotine without having to resort to smoking.

 

Researchers have found that individuals who recently quit smoking are almost more likely to use nicotine pouches daily.

 

Our research findings suggest that adults may use nicotine pouches for harm reduction purposes, as the highest rates of use are among those who have recently quit another tobacco product or e-cigarette," said Chief Researcher Cristine Delnevo. She is the director of the Rutgers University Nicotine and Tobacco Research Institute in New Brunswick, New Jersey.

 

According to the Centers for Disease Control and Prevention (CDC), nicotine pouches contain a powder made up of nicotine, flavorings, and other ingredients. Typically, people place the nicotine pouch between their lips and gums, where the nicotine is absorbed.

 

For this study, researchers analyzed survey data on tobacco use among more than 110,000 Americans collected by the US Census Bureau in 2022 and 2023.

 

Few people have ever used nicotine pouches, with approximately 2.6% of individuals reporting that they have tried them.

 

The use of nicotine pouches by individuals who have never tried any tobacco products is almost nonexistent.

 

On the contrary, individuals who use nicotine pouches are often smokers, e-cigarette users, or users of smokeless tobacco. Researchers have found that:

 

·People who smoke occasionally are 2.4 times more likely to use nicotine pouches than others. 

·Those who occasionally use e-cigarettes are 3.9 times more likely to use nicotine pouches than others. 

·Former smokers are 3.9 times more likely to use nicotine pouches than others. 

·Non-tobacco users are more than 10 times more likely to use nicotine pouches than others.

 

These numbers indicate that nicotine pouches may play a role in helping some smokers in their efforts to quit, researchers say.

 

Mary Hrywna, Associate Professor at the Rutgers School of Public Health, says that with nicotine pouches attracting increasing attention in the United States, many believe there is a need for a better understanding of who is using these products and how they are being used.

 

According to Reuters, these findings coincide with the news that the US Food and Drug Administration (FDA) is planning to expedite the review of nicotine pouches from four tobacco companies.

 

In January 2025, the FDA approved for the first time a nicotine pouch called Zyn, produced by a Swedish company. Currently, Zyn remains the only nicotine pouch approved by the FDA.

 

Dellnivo pointed out that nicotine is highly addictive and can potentially impact heart health, so the safety of nicotine pouches is still uncertain. However, nicotine itself is not associated with cancer like smoking is.

 

People who have never used tobacco products should not suddenly start using nicotine pouches," Delnevo said. "But for those who smoke or use other nicotine products and do not want to quit nicotine, switching completely from more harmful products to nicotine pouches could be beneficial for public health.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

US E-cigarette Industry Sues North Carolina Over FDA Authorization Law, Claims State Overreach in Federal Regulation
US E-cigarette Industry Sues North Carolina Over FDA Authorization Law, Claims State Overreach in Federal Regulation
U.S. e-cigarette industry sues North Carolina over FDA unauthorized sales ban, alleging overreach in federal regulation interference.
Aug.13 by 2FIRSTS.ai
Russian Academy of Sciences Scholar Calls for Comprehensive Ban on Tobacco Sales
Russian Academy of Sciences Scholar Calls for Comprehensive Ban on Tobacco Sales
Russian scientist advocates for complete ban on tobacco sales, emphasizing importance of anti-smoking legislation to improve public health.
Aug.07 by 2FIRSTS.ai
UK disposablevapee ban survey: 85% of users switch to compliant devices, 26% turn to the illegal market
UK disposablevapee ban survey: 85% of users switch to compliant devices, 26% turn to the illegal market
New study reveals 85% of e-cigarette users switch to reusable devices, highlighting challenges in transition and increased tobacco use.
Aug.08 by 2FIRSTS.ai
Kazakhstan Prosecutor General’s Office: Illegal Import of E-Cigarettes Is a Criminal Offense, Punishable by Up to 2 Years in Prison
Kazakhstan Prosecutor General’s Office: Illegal Import of E-Cigarettes Is a Criminal Offense, Punishable by Up to 2 Years in Prison
Kazakhstan’s Prosecutor General’s Office and financial authorities discussed illegal e-cigarette imports. A 2024 law criminalizes importation, punishable by up to two years in prison. Since early 2025, 16 smuggling cases were recorded, nine now in court. Legal awareness campaigns are ongoing at airports, stations, and customs.
Jul.23 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
Malawi relies heavily on tobacco, which generates over 50% of foreign exchange and 12% of GDP. In 2025, output is expected to reach 175 million kg, but lower prices and rising costs hurt profits. TAMA CEO Nixon Lita discusses climate effects, market pressures, diversification, and challenges from next-generation nicotine products.
Jul.30